Digital Health &
on site COVID testing

On-site physician assisted testing via telemedicine platform that is fast and efficient at $0 direct cost with no out of pocket or copays required.  We can process your group through the testing process faster and more efficiently; averaging between 40-55 patients per queue per hour.  We can support up to 10 or more simultaneous queues.  

 Almost all competing tests done today are “pooled” (grouped together) and rely on a light signature that is imprecise, thus reducing test sensitivity resulting in higher instances of false negatives, false positive and indeterminate results when there are low viral loads. 

The QRMDs accuracy provides you greater assurance that you can take comfort in receiving a negative result or positive result and also allows you to be proactive at an earlier stage if Covid-19 is detected, even if symptoms have not developed.  

The vaccines are working well.  Very well and research supports the notion that vaccinated people do not suffer serious adverse reactions to infection from the virus.  However the vaccinations do NOT prevent infection, and likely those infected are probably asymptomatic.  Therefore unless your entire population in your group is vaccinated, and their families, robust testing and surveillance is the best way to stop proliferation of the infection in your group. 

in a recent publication the CDC recommends amongst other measures, “Use of a frequent SARS-CoV-2 screening testing program for students, teachers, and staff ” for schools with K-12 students.  That article can be seen here

All tests performed by QRMDs are based solely on medical necessity documented in our process 3 times during each patient encounter.  We certify medical necessity and base our physician authorization on medical necessity decision criteria.  As such, pursuant to the CARES Act, all diagnostic testing and services are covered without any copay or deductible obligations.  

If the costs are denied by the insurance company, there is no recourse to you or your organization. 

The program covers both insured and uninsured individuals alike.  

If your group members are not qualified as being medically necessary,  you will be notified in advance and asked if you would like to pay for the cost of the testing or test.  You will not incur any surprise charges with regard to the program

The CARES Act provides that all diagnostic testing for all individuals, even if asymptomatic, are to be reimbursed without copay or deductible charges assessed.  Documenting medical necessity, and our individual clinical review, ensures that  all testing is in compliance with the CARES Act.  There are no direct costs to the group or patients.  

The steps are fairly simple.

First, you assign a liaison and site coordinator to manage the logistical coordination for the testing along with an assigned QRMDs designating point person.

Second, each member of your organization must register as a patient and sign the appropriate consent forms.

Third, you establish the days you would like to test, how many people within your organization you want to test with what frequency. 

Fourth, you will establish a location to establish a televisit or multiple locations at your facility .  Your assigned logistics person can help with that. 

With our proprietary patent pending AI based software we can facilitate testing ~50 people per hour per queue.  Multiple queues can be easily set up so that capacity is scaled accordingly. 

All samples are individually sequenced and lab results are delivered 98% of the time the next day after receipt by the laboratory.  

Each participant will receive a collection kit either from your organization’s administrator or shipped directly to their home. The kit contains detailed easy to follow instructions and diagrams to help guide the collection of the sample. The participant will self-collect their sample from home or designated site following the instructions provided. This is an easy to follow and gentle process, no different to using a cotton swab to clean the inside of your nose. To help ensure proper collection, all test collections will be assisted and supervised by a medical provider via a video call through the QRMDs website.

Yes. While the vaccine may prevent you from getting sick, it will not prevent you from contracting the virus.  You will not likely develop symptoms, but can still be a carrier.  Testing should be done to see if you have the virus and are unintentionally capable of asymptomatically spreading it.   That is why, until more is understood about how well the vaccine works, continuing with precautions such as mask-wearing and physical distancing will be important. (Lisa Maragakis, M.D., M.P.H., senior director of infection prevention, and Gabor Kelen, M.D., director of Johns Hopkins Office of Critical Event Preparedness and Response).

 Testing will enable you to identify whether you are still carrying the virus. 

Currently, as of February ’21, as long as it is determined that the testing is medically necessary to test your group members (employees, students etc.) the costs are covered by insurance benefits.

The bar for medical necessity currently is very low.  This could and likely will change over time.  As this develops and matures your account executive will work with you to assist you in identifying the accurate and correct testing days and frequency. 

This depends upon the current infection rate within your area(s) and other factors such as how often your group interacts with others.

Generally the idea is to catch an infection in one or more group members prior to them infecting the rest of the general population of your group to prevent an outbreak within your facility or location. 

To best serve this we reccomend you test twice a week on Monday/Tuesday and again on Thursday or Friday.  in this way the tests you run on Thursday will report results on Saturday which gives you the opportunity to keep those infected in your group from returning on Monday.  Subsequently you can follow up with testing on Monday or Tuesday, to be sure you catch the infected at the earliest possible time.